Egg Quality vs Egg Quantity: What Really Matters for IVF Success

Two Different Questions, One Confusing Conversation

When people start researching fertility treatment, they often run into two numbers that sound like they should tell the same story: ovarian reserve testing and egg quality. In reality, these measure two very different things. Ovarian reserve tells you roughly how many eggs a woman has remaining. It says almost nothing about how healthy those eggs are. Understanding the difference between egg quality and egg quantity is one of the most useful things a patient can learn before starting an IVF journey, because it changes what tests actually mean and what outcomes to realistically expect.

What Egg Quantity Actually Measures

Egg quantity refers to the number of eggs remaining in the ovaries, often called ovarian reserve. This is typically estimated using two tools: the AMH blood test, which measures anti-Mullerian hormone produced by small ovarian follicles, and the antral follicle count, an ultrasound count of the small follicles visible at the start of a menstrual cycle. Both give a useful estimate of how many eggs might be retrieved during an IVF stimulation cycle.

A higher AMH or AFC generally means more eggs are likely to be collected in a stimulation cycle. A lower result usually means fewer eggs, and it may prompt a fertility specialist to adjust medication protocols. What these tests do not do is tell you anything about the genetic or developmental health of those eggs. A woman with a low ovarian reserve can still have eggs of very good quality, and a woman with a high egg count is not guaranteed that those eggs are chromosomally normal.

Why Quantity Testing Still Matters

Even though quantity does not equal quality, ovarian reserve testing remains clinically important. It helps a fertility specialist estimate how a patient might respond to stimulation medication, plan dosing, and set realistic expectations about how many eggs a retrieval cycle might yield. It is a planning tool, not a quality forecast.

What Egg Quality Actually Means

Egg quality refers to an egg’s chromosomal normality and its developmental competence, meaning its ability to be fertilized, divide correctly, and support a healthy pregnancy. Unlike quantity, egg quality cannot currently be measured directly through a blood test or scan before retrieval. Its effects are usually seen indirectly, through fertilization rates, embryo development in the laboratory, or through genetic testing of embryos after they have formed.

This is an important honesty point for patients to understand. There is no reliable test that looks at an egg while it is still in the ovary and reports back “this one is high quality.” Quality becomes visible only once an egg is fertilized and an embryo begins to develop, or through chromosomal testing of the resulting embryo.

Why Quality Often Matters More Than Quantity

For many patients pursuing pregnancy, egg quality plays a larger role in the outcome than the sheer number of eggs available. A cycle that yields fewer eggs but where those eggs are chromosomally normal can still lead to a healthy pregnancy. Conversely, a cycle that yields many eggs but where a high proportion carry chromosomal abnormalities may result in failed fertilization, embryos that stop developing, or pregnancy loss, even though the ovarian reserve numbers looked favorable on paper.

This is why a patient’s AMH result alone should never be read as a prediction of IVF success. Egg quality is what most directly determines whether fertilization occurs, whether an embryo develops normally, and whether a pregnancy is likely to be sustained.

Age: The Single Biggest Driver of Egg Quality

Of all the factors that influence egg quality, age is by far the most significant. Studies report that the proportion of chromosomally normal eggs declines as women get older, with a more noticeable shift generally occurring from the mid to late thirties onward and accelerating further in the forties. This happens because eggs are formed early in life and age along with the body, making them more prone to errors in chromosome division over time.

This is also why a woman in her twenties or early thirties with a lower than average AMH can still have strong pregnancy chances, since her eggs are more likely to be chromosomally normal even if fewer are retrieved. Age-related quality decline is a biological process that current medicine cannot reverse, and any product or protocol claiming to restore younger egg quality should be viewed with caution.

What Can and Cannot Be Changed

It is understandable that patients want to know what they can actively do to support their eggs. Being honest about this matters. Lifestyle factors such as not smoking, maintaining a balanced diet, managing weight within a healthy range, limiting alcohol, managing stress, and treating underlying conditions like thyroid disorders or insulin resistance can support overall reproductive health and may improve the environment in which eggs mature. However, current evidence does not show that lifestyle changes or supplements can reverse the chromosomal aging of eggs that comes with time. Claims promising to significantly improve egg quality or turn back reproductive age are not supported by strong clinical evidence, and patients should be cautious of marketing that suggests otherwise.

What can be changed through medical care is how a fertility team works with the eggs a patient has now, through optimized stimulation protocols, laboratory technique, and, where appropriate, genetic testing of embryos.

Where PGT-A and IVF Fit Into the Picture

Preimplantation genetic testing for aneuploidy, or PGT-A, allows embryos created through IVF to be screened for chromosomal abnormalities before transfer. This can help identify embryos that are more likely to be chromosomally normal, which may support informed decisions about which embryo to transfer, particularly for patients with a history of pregnancy loss or for those of advanced maternal age. It is worth noting that evidence on how much PGT-A improves overall live birth rates per cycle for every patient group is mixed, and it is not automatically recommended for everyone. A fertility specialist can help evaluate whether it is a reasonable option for a specific situation. For patients with a known family history of an inherited genetic condition, embryo testing can also help reduce the chance of passing that condition to a child.

Frequently Asked Questions

Can a high AMH mean my eggs are good quality?

Not necessarily. AMH reflects how many eggs are likely available, not their chromosomal health. Quality is influenced mainly by age and other individual factors, not by the AMH number itself.

Does low ovarian reserve mean IVF will not work?

Not necessarily. A lower egg count can mean fewer eggs are retrieved per cycle, but if those eggs are chromosomally normal, a healthy pregnancy is still possible. Outcomes vary by age and individual circumstances, and a fertility specialist can help set realistic expectations based on a full evaluation.

Is there a supplement that reliably improves egg quality?

No supplement has been shown to reliably reverse age-related decline in egg quality. Some supplements are commonly discussed in fertility care, but the evidence remains limited and individual results vary, so it is best to discuss any supplement with a fertility specialist rather than self-prescribing.

Why do doctors talk about quantity so much if quality matters more?

Quantity is measurable before treatment starts and helps plan stimulation protocols, while quality can generally only be assessed once embryos develop. Both pieces of information are used together to guide a personalized treatment plan.

Every fertility journey is different, and numbers on a lab report only tell part of the story. If you would like a clearer picture of your own ovarian reserve and what it may mean for your treatment options, the team at GynoLife IVF Center in Cyprus can walk you through personalized testing and an honest discussion of your path forward.